Announcements Trials
Browse Landscape

Phase

Phase 2 33Phase NA 14Phase 1 11Phase 1/2 6Phase EARLY_PHASE1 2Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Brain Neoplasms 23Carcinoma, Non-Small-Cell Lung 15Neoplasm Metastasis 14Carcinoma, Hepatocellular 11Lung Neoplasms 10Prostatic Neoplasms 9Breast Neoplasms 5Neoplasms 4Melanoma 3Carcinoma, Renal Cell 3Small Cell Lung Carcinoma 2Colorectal Neoplasms 2Central Nervous System Neoplasms 2Stage II Prostate Adenocarcinoma AJCC v7 1Sarcoma, Ewing 1Radiation Therapy 1Radiation Injuries 1Prostatic Neoplasms, Castration-Resistant 1Prostate Cancer Metastatic 1Pituitary Neoplasms 1Patients Receiving Fractionated Stereotactic Radiotherapy 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Neoplasms 1Oligometastatic Hormone Sensitive Prostate Cancer 1Neurotoxicity Syndromes 1Neuroma, Acoustic 1Nasopharyngeal Carcinoma 1Kidney Neoplasms 1Head and Neck Neoplasms 1Growth Hormone-Secreting Pituitary Adenoma 1

Interventions

Gemcitabine 73Fluorouracil 30Oxaliplatin 20Leucovorin 20130-nm albumin-bound paclitaxel 16Capecitabine 14Irinotecan 11Albumin-Bound Paclitaxel 10irinotecan sucrosofate 8Radiotherapy 6Taxes 5Erlotinib Hydrochloride 5folfirinox 4rubitecan 3Surgical Procedures, Operative 3Specimen Handling 3Pancreaticojejunostomy 3Neoadjuvant Therapy 3Drug Therapy 3Cisplatin 3Chemotherapy, Adjuvant 3ruxolitinib 2masitinib 2dehydroftorafur 2Saline Solution 2S 1 (combination) 2Paclitaxel 2GV1001 peptide 2Fentanyl 2Bevacizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Pancreatic Neoplasms × Radiosurgery × Clear all
NCT01926197 2022-10-28

Phase 3 Study of FOLFIRINOX (mFFX) +/- SBRT in Locally Advanced Pancreatic Cancer

Stanford University

Phase 3 Completed
27 enrolled 15 charts
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡